- Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions - http://eyedocnews.com -

ISTA Pharmaceuticals Reports Results of Studies of REMURA(TM) Eye Drops for Dry Eye Disease

Posted By Dr. Ari Weitzner On October 18, 2011 @ 5:36 am In Dry Eye,Industry News | Comments Disabled

Last week, ISTA Pharmaceuticals announced top-line results from the second of its two Phase 3 studies to evaluate the short-term safety and efficacy of two concentrations of REMURA(TM) (bromfenac ophthalmic solution for dry eye) in alleviating the signs and symptoms of dry eye disease.

In the EAST study, REMURA was highly effective in treating a sign and symptom of dry eye but was not statistically significantly better than placebo in the entire patient cohort, a common outcome reported in studies testing other dry eye therapies. In both Phase 3 studies, safety data demonstrated REMURA was well-tolerated, with an adverse event profile similar to placebo and consistent with those observed previously with REMURA in a Phase 2 study and with other prescription dry eye drops. All three formulations were rated by patients as very comfortable.

Click here [1] for the full release.


Article printed from Breaking News Related to Macular Degeneration, Cataract, Glaucoma, Corneal Disease and Other Eye Conditions: http://eyedocnews.com

URL to article: http://eyedocnews.com/006180-ista-pharmaceuticals-reports-results-of-studies-of-remuratm-eye-drops-for-dry-eye-disease/

URLs in this post:

[1] Click here: http://phx.corporate-ir.net/phoenix.zhtml?c=121179&p=irol-newsArticle&ID=1616702&highlight=

Copyright © 2008 Eye Doc Talk. All rights reserved.